Established in 2004, this premier South Florida specialty pharmacy and wholesale enterprise generates $22.59M in normalized annual revenue while dispensing an average of ~550 prescriptions daily. Operating out of a 10,000 sq. ft. facility footprint with a tenured staff of 23, the business combines a high-margin specialty dispensing footprint with a rare Florida wholesale distribution license.

Unmatched Competitive Moats & Revenue Drivers
340B Contract Advantage: Holds an active 340B contract pharmacy relationship, expanding profit margins on high-cost specialty medications. Rare Florida Wholesale License: Includes an active Florida retail wholesale distribution license—a scarce, highly sought-after asset that serves as a massive barrier to entry and opens B2B expansion channels.
High-Margin HIV Collaborative Agreement: Newly executed collaborative agreement permits direct HIV testing and prescribing under 340B in a top national demand market.
Full Payer Access & Institutional Network: Fully in-network with all major insurance carriers/PBMs, backed by an established detox/LTC facility referral channel. Immediate Consolidation Synergy:
Merging duplicate operations instantly eliminates redundant rent, payroll, and licensing fees, driving an estimated ~$180,000 directly to the bottom-line net profit.

Next Steps
High-volume 340B specialty pharmacies with active wholesale distribution licenses in Florida rarely hit the open market. Serious prospective buyers must execute a Non-Disclosure Agreement (NDA) and provide Proof of Funds to receive the complete Confidential Information Memorandum (CIM) and financial package. Contact AcquiTrust M&A Advisory today to secure your position!
— AcquiTrust | Owner-Led. AI-Powered. Acquisition Specialists.